A detailed history of J.W. Cole Advisors, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 14,305 shares of TMDX stock, worth $2.37 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
14,305
Holding current value
$2.37 Million
% of portfolio
0.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$72.62 - $150.62 $1.04 Million - $2.15 Million
14,305 New
14,305 $2.15 Million
Q4 2023

Jan 31, 2024

SELL
$36.74 - $81.08 $383,896 - $847,204
-10,449 Reduced 61.56%
6,526 $515,000
Q3 2023

Oct 24, 2023

BUY
$53.47 - $96.07 $907,653 - $1.63 Million
16,975 New
16,975 $929,000
Q1 2023

May 03, 2023

BUY
$53.63 - $82.33 $275,121 - $422,352
5,130 New
5,130 $388,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $5.28B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track J.W. Cole Advisors, Inc. Portfolio

Follow J.W. Cole Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.